Medical journals are an extension of the marketing arm of pharmaceutical companies

被引：279

作者：

Smith, R ^{[1
]}

机构：

[1] UnitedHlth Europe, London, England

来源：

PLOS MEDICINE | 2005年 / 2卷 / 05期

关键词：

D O I：

10.1371/journal.pmed.0020138.g001

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：364 / 366

页数：3

共 21 条

[1]

Angell Marcia., 2005, The Truth about the Drug Companies: How They Deceive Us and What to Do about It

[2]

BARBOUR V, 2004, PLOS MED, V1, pE22, DOI DOI 10.1371/JOURNAL.PMED.0010022

[3] The quality of drug studies published in symposium proceedings [J].

Cho, MK ;

Bero, LA .

ANNALS OF INTERNAL MEDICINE, 1996, 124 (05) :485-+

[4] Sponsorship, authorship, and accountability [J].

Davidoff, F ;

DeAngelis, CD ;

Drazen, JM ;

Hoey, J ;

Hojgaard, L ;

Horton, R ;

Kotzin, S ;

Nicholls, MG ;

Nylenna, M ;

Overbeke, AJPM ;

Sox, HC ;

Van Der Weyden, MB ;

Wilkes, MS .

LANCET, 2001, 358 (9285) :854-856

[5] Clinical trial registration: a statement from the International Committee of Medical journal Editors [J].

De Angelis, C ;

Drazen, JM ;

Frizelle, FA ;

Haug, C ;

Hoey, J ;

Horton, R ;

Kotzin, S ;

Laine, C ;

Marusic, A ;

Overbeke, AJPM ;

Schroeder, TV ;

Sox, HC ;

Van der Weyden, MB .

LANCET, 2004, 364 (9438) :911-912

[6] Are randomised controlled trials in the BMJ different? [J].

Egger, M ;

Bartlett, C ;

Jüni, P .

BRITISH MEDICAL JOURNAL, 2001, 323 (7323) :1253-1254

[7]

GARROW J, 2005, HEALT WATCH, V56, P4

[8]

Godlee F, 2003, Peer Review in Health Sciences, V2nd

[9]

HORTON R, 2004, DAWN MCSCIENCE, V51, P7

[10] Redundancy, disaggregation, and the integrity of medical research [J].

Huston, P ;

Moher, D .

LANCET, 1996, 347 (9007) :1024-1026

← 1 2 3 →